Search

Author/Creator Harada, Shigeru

1. Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma progressing after molecular targeted therapy: A multicenter prospective observational study. Issue 40 (7th October 2022)

Authors:
Sugimoto, Rie; Satoh, Takeaki; Ueda, Akihiro; Senju, Takeshi; Tanaka, Yuki; Yamashita, Shinsaku; Koyanagi, Toshimasa; Kurashige, Tomoyuki; Higuchi, Nobito; Nakamura, Tsukasa; Tanaka, Masatake; Azuma, Yuuki; Ohno, Akari; Ooho, Aritsune; Ooe, Mari; Mutsuki, Taiji; Uchimura, Koutarou; Kuniyoshi, Mas...
Journal:
Medicine
Issue:
Volume 101:Issue 40(2022)
Page Start:
e30871
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Successful immunomodulation in kidney transplant recipients with cytokine release syndrome after coronavirus disease. Issue 5 (24th June 2022)

Authors:
Takamoto, Daiji; Sasaki, Hajime; Kataoka, Hiroshi; Kodama, Fumihiro; Higuchi, Haruka; Hirano, Tetsuo; Takada, Yusuke; Harada, Shigeru; Harada, Hiroshi; Tanaka, Hiroshi
Journal:
IJU case reports
Issue:
Volume 5:Issue 5(2022)
Page Start:
373
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗